The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

IMW 2019 | Treating smoldering myeloma

Name: Treating smoldering myeloma
Uploaded: 2019-09-12T00:00:00.000Z
Duration: 1 min 59 s
Description: Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the important question of how we should treat smoldering myeloma, specifically mentioning the use of precision medicine. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Irene Ghobrial • 12 Sep 2019

IMW 2019

Multiple Myeloma Rare Diseases Smoldering Myeloma

Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the important question of how we should treat smoldering myeloma, specifically mentioning the use of precision medicine. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.